LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian Cancer
Conclusion: Our results support a possible role of LRP1B as a predictor of response to PLD in patients with OC.Pathobiology
Source: Pathobiology - Category: Pathology Source Type: research
More News: Cancer | Cancer & Oncology | Environmental Health | Genetics | Ovarian Cancer | Ovaries | Pathology | Study